BibTex RIS Cite

An exceedingly rare entity: Mixed cellular type primary Hodgkin

Year 2012, , 533 - 535, 01.12.2012
https://doi.org/10.5799/ahinjs.01.2012.04.0216

Abstract

Primary mixed cellularity Hodgkin\'s lymphoma of the parotid gland is extremely rare. We report here an 80-year old woman who presented with a painless preauricular mass of two months duration. Cytological and histomorphological findings were consistent with mixed cellularity Hodgkin\'s lymphoma. Due to the age and the presence of comorbid diseases, the patient only received radiotheraphy and has been in remission for 12 months since the initial diagnosis. Primary Mixed cellularity Hodgkin\'s lymphoma of the parotid gland is extremely rare and the prognosis, in addition to the biologic behavior of this disease is yet to be evaluated.

References

  • Iyengar P, Mazloom A, Shihadeh F, Berjawi G, Dabaja B. Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes. Cancer 2010; 116 (16): 3825-9.
  • Masuda M, Segawa Y, Joe AK, Hirakawa N, Komune S. A case of primary Hodgkin’s lymphoma of the parotid gland. Auris Nasus Larynx 2008; 35 (3): 440-2.
  • Nassie DI, Berkowitz M, Wolf M, Kronenberg J, Takmi YP. Parotid mass as presenting symptom of lympho- ma. Isr Med Assoc J 2010; 12 (7): 416-8.
  • Yencha MW. Primary parotid gland Hodgkin’s lympho- ma. Ann Otol Rhinol Laryngol 2002; 111 (4): 338-42.
  • Chan ACL, Chan JKC, Abbondanzo SL. Haematolym- phoid tumours, in Textbook Pathology & Genetics Head and NeckTumors, World health organization classification of tumours 2005. Barnes L, Eveson JW, Reichart P and Sidransky D, Eds., IARC Press, Lyon, France 2005 pp. 277-80.
  • Barnes L, Myers EN, Prokopakis EP. Primary malig- nant lymphoma of the parotid gland. Arch Otolaryngol Head Neck Surg 1998;124 (5):573-7.

Son derece nadir bir durum: Parotis bezinin miks sellüler tip primer Hodgkin lenfoması

Year 2012, , 533 - 535, 01.12.2012
https://doi.org/10.5799/ahinjs.01.2012.04.0216

Abstract

Parotis bezinin miks sellüler tip primer hodgkin lenfoması son derece nadir görülür. Biz burada 2 aydır olan ağrısız preaurikular kitle ile başvuran 80 yaşında bir kadın hastayı sunduk. Sitolojik ve histomorfolojik bulgular miks sellüler tip hodgkin lenfoma ile uyumlu bulundu. Yaş ve komorbid hastalıklarından ötürü hastaya sadece radyoterapi verildi. Hastanın, tanıdan itibaren 12 aydır remisyonda takibi devam ediyor. Parotis bezinin Miks sellüler tip primer hodgkin lenfoması son derece nadirdir ve bu hastalığın biyolojik davranışı ve prognozu araştırılmayı beklemektedir.

References

  • Iyengar P, Mazloom A, Shihadeh F, Berjawi G, Dabaja B. Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes. Cancer 2010; 116 (16): 3825-9.
  • Masuda M, Segawa Y, Joe AK, Hirakawa N, Komune S. A case of primary Hodgkin’s lymphoma of the parotid gland. Auris Nasus Larynx 2008; 35 (3): 440-2.
  • Nassie DI, Berkowitz M, Wolf M, Kronenberg J, Takmi YP. Parotid mass as presenting symptom of lympho- ma. Isr Med Assoc J 2010; 12 (7): 416-8.
  • Yencha MW. Primary parotid gland Hodgkin’s lympho- ma. Ann Otol Rhinol Laryngol 2002; 111 (4): 338-42.
  • Chan ACL, Chan JKC, Abbondanzo SL. Haematolym- phoid tumours, in Textbook Pathology & Genetics Head and NeckTumors, World health organization classification of tumours 2005. Barnes L, Eveson JW, Reichart P and Sidransky D, Eds., IARC Press, Lyon, France 2005 pp. 277-80.
  • Barnes L, Myers EN, Prokopakis EP. Primary malig- nant lymphoma of the parotid gland. Arch Otolaryngol Head Neck Surg 1998;124 (5):573-7.
There are 6 citations in total.

Details

Primary Language Turkish
Journal Section Case Report
Authors

Aynur Albayrak This is me

Murat Albayrak This is me

Ata Türker Arıkök This is me

Tuba Dilay Kökenek Ünal This is me

Demet Yılmazer This is me

Publication Date December 1, 2012
Published in Issue Year 2012

Cite

APA Albayrak, A., Albayrak, M., Arıkök, A. T., Ünal, T. D. K., et al. (2012). Son derece nadir bir durum: Parotis bezinin miks sellüler tip primer Hodgkin lenfoması. Journal of Clinical and Experimental Investigations, 3(4), 533-535. https://doi.org/10.5799/ahinjs.01.2012.04.0216
AMA Albayrak A, Albayrak M, Arıkök AT, Ünal TDK, Yılmazer D. Son derece nadir bir durum: Parotis bezinin miks sellüler tip primer Hodgkin lenfoması. J Clin Exp Invest. December 2012;3(4):533-535. doi:10.5799/ahinjs.01.2012.04.0216
Chicago Albayrak, Aynur, Murat Albayrak, Ata Türker Arıkök, Tuba Dilay Kökenek Ünal, and Demet Yılmazer. “Son Derece Nadir Bir Durum: Parotis Bezinin Miks sellüler Tip Primer Hodgkin Lenfoması”. Journal of Clinical and Experimental Investigations 3, no. 4 (December 2012): 533-35. https://doi.org/10.5799/ahinjs.01.2012.04.0216.
EndNote Albayrak A, Albayrak M, Arıkök AT, Ünal TDK, Yılmazer D (December 1, 2012) Son derece nadir bir durum: Parotis bezinin miks sellüler tip primer Hodgkin lenfoması. Journal of Clinical and Experimental Investigations 3 4 533–535.
IEEE A. Albayrak, M. Albayrak, A. T. Arıkök, T. D. K. Ünal, and D. Yılmazer, “Son derece nadir bir durum: Parotis bezinin miks sellüler tip primer Hodgkin lenfoması”, J Clin Exp Invest, vol. 3, no. 4, pp. 533–535, 2012, doi: 10.5799/ahinjs.01.2012.04.0216.
ISNAD Albayrak, Aynur et al. “Son Derece Nadir Bir Durum: Parotis Bezinin Miks sellüler Tip Primer Hodgkin Lenfoması”. Journal of Clinical and Experimental Investigations 3/4 (December 2012), 533-535. https://doi.org/10.5799/ahinjs.01.2012.04.0216.
JAMA Albayrak A, Albayrak M, Arıkök AT, Ünal TDK, Yılmazer D. Son derece nadir bir durum: Parotis bezinin miks sellüler tip primer Hodgkin lenfoması. J Clin Exp Invest. 2012;3:533–535.
MLA Albayrak, Aynur et al. “Son Derece Nadir Bir Durum: Parotis Bezinin Miks sellüler Tip Primer Hodgkin Lenfoması”. Journal of Clinical and Experimental Investigations, vol. 3, no. 4, 2012, pp. 533-5, doi:10.5799/ahinjs.01.2012.04.0216.
Vancouver Albayrak A, Albayrak M, Arıkök AT, Ünal TDK, Yılmazer D. Son derece nadir bir durum: Parotis bezinin miks sellüler tip primer Hodgkin lenfoması. J Clin Exp Invest. 2012;3(4):533-5.